Growth Metrics

DBV Technologies (DBVT) Accumulated Depreciation & Amortization (2019 - 2025)

DBV Technologies (DBVT) reported Accumulated Depreciation & Amortization of $3.0 million for Q4 2025, up 10.25% year-over-year from $2.7 million in Q4 2024, and up 10.25% on a QoQ basis from $2.7 million in Q4 2024.

DBV Technologies (DBVT) has 7 years of Accumulated Depreciation & Amortization data on file, last reported at $3.0 million in Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 10.25% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 10.25% YoY) and the FY2025 annual result came in at $3.0 million, up 10.25% from the prior year.
  • Accumulated Depreciation & Amortization rose to $3.0 million in Q4 2025 per DBVT's latest filing, from $2.7 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $14.8 million in Q4 2022 and bottomed at $2.7 million in Q4 2024.
  • The 5-year median for Accumulated Depreciation & Amortization is $3.6 million (2023), against an average of $7.6 million.
  • The widest annual swing landed in 2023, when Accumulated Depreciation & Amortization plunged 75.66%; it then grew 10.25% in 2025.
  • Tracing DBVT's Accumulated Depreciation & Amortization over 5 years: stood at $13.8 million in 2021, then increased by 7.17% to $14.8 million in 2022, then sank by 75.66% to $3.6 million in 2023, then declined by 24.42% to $2.7 million in 2024, then gained by 10.25% to $3.0 million in 2025.
  • Per Business Quant, the three latest DBVT Accumulated Depreciation & Amortization figures stand at $3.0 million (Q4 2025), $2.7 million (Q4 2024), and $3.6 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 3.00 Mn
Dec 31, 2025 3.00 Mn
Dec 31, 2024 2.72 Mn
Dec 31, 2024 2.72 Mn
Dec 31, 2023 3.60 Mn
Dec 31, 2023 3.60 Mn
Dec 31, 2022 14.79 Mn
Dec 31, 2022 14.79 Mn
Dec 31, 2021 13.80 Mn
Dec 31, 2021 13.80 Mn
Dec 31, 2020 16.69 Mn
Dec 31, 2020 16.69 Mn
Dec 31, 2019 11.47 Mn
Dec 31, 2019 11.47 Mn